Latest
US stocks slip as Walmart drags; Moderna surges before retreat
S&P 500, Dow and Nasdaq fall after Walmart’s weak quarter and rising oil prices. Moderna jumps 177% before paring gains. SMI also declines as Logitech, Swiss Re drop.
Commerzbank retires shares as UniCredit nears majority stake
UniCredit’s stake in Commerzbank rises to 49.65% after share buyback retirement, with 3.36% subject to conversion options. Commerzbank’s board had delayed retirement amid takeover dispute.
China semiconductor equipment imports rise 9% in July, led by Shanghai
July marked the first year-over-year increase in 2026 as logic chip demand drove a 9% rise in imports, with lithography and assembly equipment leading gains. Barclays forecasts further acceleration in H2.
LandBridge shares jump 9.6% on Texas conversion and Barron’s spotlight
Stock surges to a new 52-week high after SEC filing to reincorporate in Texas and a Barron’s article highlighting technical setups in water infrastructure plays.
Kinepolis posts 32.6% H1 2026 revenue jump as cinema demand surges
Net profit more than tripled to EUR 28.1 million on strong box office and in-theater sales growth. Stock nears 52-week high after earnings call.
Tonies SE posts 41% H1 2026 revenue growth as shares dip
Strong sales growth driven by North America and new product launches offset margin compression and sent shares down 4.2% in pre-market trading.
Austevoll Seafood Q2 2026 profit falls short as Peru operations weigh on results
Norwegian seafood group Austevoll Seafood reported an 11% revenue miss and a net loss of 254 million NOK in Q2 2026, as El Niño-driven disruptions in Peru and Chile disrupted pelagic operations.
Greenland Mines shares drop 19% after 1-for-50 reverse split plan
The NASDAQ-listed miner’s stock fell sharply after announcing a reverse stock split to meet Nasdaq’s listing requirements. Operations continue at the Skaergaard gold-palladium project in East Greenland.
Canada, U.S. trade negotiators meet as tariff deadline approaches
Top officials from Ottawa and Washington convened for a second day of talks to avert a looming 50% tariff on $20 billion of Canadian goods. A deal on vehicles, steel and aluminum appears within reach.
JD.com offers EU concessions in Ceconomy takeover probe
Chinese e-commerce giant proposes remedies to address Brussels' concerns over MediaMarkt-Saturn deal. EU regulator targets alleged state subsidies and deepens antitrust scrutiny.
Wolfe Research flags Amazon, Alphabet, DoorDash as top stock picks
Analysts highlight cloud computing, digital advertising and food delivery as key sectors for the next 12 months. Amazon’s AWS growth and $18bn Louisiana data center expansion lead the recommendations.
U.S. accused of interest-rate manipulation after doubling bond buybacks
Criticism of the Swiss National Bank’s currency interventions highlights parallels with Washington’s bond-market interventions, which similarly distort market pricing. Analysis of policy overlap and unintended consequences.
US stocks fall as Walmart drags; Moderna surges then pares gains
Moderna’s shares soar 177% before paring gains to 140% above Tuesday’s close. Walmart’s weak quarter weighs on retail peers. SMI and Swiss indices decline as oil prices rise.
Sugar futures surge to over one-year highs on supply tightness
Raw sugar prices hit 17.99 cents per pound, while white sugar reached $564.40 per ton amid concerns over El Nino and India’s potential import shift. Brazil’s output forecast also weighs on market.
Cosmos Health secures five-year Saudi distribution deal for supplements
Innova Healthcare, majority-owned by Alkhabeer Capital, will exclusively distribute Cosmos Health's Sky Premium Life supplements across Saudi Arabia over a five-year term with an option to renew.
US stocks slip on Walmart earnings, oil prices; SMI extends losses
Walmart shares drop 6% on weak U.S. sales; Deere gains 4% on upbeat outlook. Brent crude hits $94/bbl as Middle East tensions rise. SMI falls 0.45% with Logitech, Swiss Re leading declines.
Medivir posts SEK 253.5m cash position after Q2 2026 earnings
Swedish biotech raises SEK 140m via oversubscribed share issue while advancing fostrox in liver cancer and MIV-711 in rare bone diseases. Net turnover declines to SEK 1.2m.
IMF hails Lebanon bank law changes as ‘major step’ amid crisis
Parliament passes amendments to bank resolution framework, meeting 99% of IMF demands, but president’s approval and Constitutional Council review still pending.
G7 government debt pressures mount as borrowing costs surge
U.S. debt tops $40 trillion while Japanese and German yields hit multi-decade highs. OECD interest payments overtake defense spending.
Greenland Mines approves 1-for-50 reverse stock split, GRML ticker retained
Nasdaq-listed Greenland Mines Ltd will reduce its share count from 158.85 million to 3.18 million under the split, effective Sunday. The move targets compliance with Nasdaq's minimum bid price rule.
Swiss utility BKW shares fall 1.1% on weak H1 2026 results
BKW AG reported a 3.1% drop in operating income to CHF 2.18 billion, with EBITDA and EBIT declining 10.1% and 15.1%, respectively. Net profit rose 7% to CHF 217.6 million.
SEC unveils crypto rules proposal, drawing bipartisan praise
Commissioners Hester Peirce and Paul Atkins commend new SEC framework as a shift from enforcement-only approach to clearer digital asset oversight amid stalled Senate legislation.
AI bots waste millions of hours of scammers' time, firms say
Australian startup Apate deploys nearly 200,000 AI personas to engage fraudsters, extracting intelligence for banks and telcos while disrupting illicit operations.
Ultragenyx shares jump 14% after FDA approves first gene therapy
GENGLYCOS granted accelerated approval for glycogen storage disease type Ia, marking Ultragenyx's fifth FDA authorization and first gene therapy. Shares rose 14% in after-hours trading.